The Journal of Immunology · 2002 · 168 citations · 83 references
Life SciencesImmunologyOncologyAdaptive ImmunityCancer ImmunologyTumor ImmunologyAntigen RecognitionCytotoxic T Lymphocyte ResponsesLymphoid NeoplasmsOncogenic VirusesT Cell BiologyT Cell Responses To TumorsCd4 Positive T CellsCd4 T Cell ActivationCd8 Positive T CellsCellular Immune Response To VirusesEpstein-barr Virus - Associated Lymphoid NeoplasmsImmune Recognition ReceptorsMhc Class I MoleculesT-cell Epitopes
The gamma-herpesvirus, EBV, is reliably found in a latent state in endemic Burkitt's lymphoma. A single EBV gene product, Epstein-Barr nuclear Ag 1 (EBNA1), is expressed at the protein level. Several mechanisms prevent immune recognition of these tumor cells, including a block in EBNA1 presentation to CD8(+) killer T cells. Therefore, no EBV-specific immune response has yet been found to target Burkitt's lymphoma. We now find that EBNA1-specific, Th1 CD4(+) cytotoxic T cells recognize Burkitt's lymphoma lines. CD4(+) T cell epitopes of EBNA1 are predominantly found in the C-terminal, episome-binding domain of EBNA1, and approximately 0.5% of peripheral blood CD4(+) T cells are specific for EBNA1. Therefore, adaptive immunity can be directed against Burkitt's lymphoma, and perhaps this role for CD4(+) Th1 cells extends to other tumors that escape MHC class I presentation.
83
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
M. A. Epstein, B. G. Achong, Y. M. Barr · The Lancet · 1964 · 2.8K citations
Epstein-Barr virus and its replication
Elliott Kieff · Medical Entomology and Zoology · 1996 · 1.6K citations
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Ulrich S. Schubert, Luis C. Antón, James S. Gibbs et al. · Nature · 2000 · 1.5K citations